Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer-Reference-Cited by-同舟云学术

Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer

Published:2015-08 Issue:2 Volume:138 Page:246-251
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Suidan Rudy S.,Leitao Mario M.,Zivanovic Oliver,Gardner Ginger J.,Long Roche Kara C.,Sonoda Yukio,Levine Douglas A.,Jewell Elizabeth L.,Brown Carol L.,Abu-Rustum Nadeem R.,Charlson Mary E.,Chi Dennis S.

Funder

Roy M. Speer Foundation

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference35 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J. Clin.,2015

2. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols;J. Clin. Oncol.,2003

3. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study;Winter;J. Clin. Oncol.,2007

4. Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis;Chang;Gynecol. Oncol.,2013

5. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach;Chi;Gynecol. Oncol.,2004

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermic intraperitoneal chemotherapy (HIPEC) vs. postoperative intraperitoneal (IP) chemotherapy – Impact on health-related quality of life in primary ovarian cancer patients after cytoreductive surgery;Surgical Oncology Insight;2024-09

2. Prognostic value and association of the age-adjusted Charlson Comorbidity Index with sarcopenia within patients with gastric cancer after radical resection;Journal of Gastrointestinal Surgery;2024-07

3. Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy;Oncology in Clinical Practice;2024-06-06

4. Predictive value of the Adult Comorbidity Evaluation 27 on adverse surgical outcomes and survival in elderly with advanced epithelial ovarian cancer undergoing cytoreductive surgery;European Journal of Medical Research;2024-03-17

5. Evaluating the Effectiveness of the Charlson Comorbidity Index in Predicting Immune Checkpoint Inhibitor-Related Adverse Events;Immunotherapy;2024-01-30